SCHEMBL692834

SCHEMBL692834

NC(O)CCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27881539 1.00
SCHEMBL16306471 1.00
SCHEMBL1142305 0.97
SCHEMBL7034445 0.83
SCHEMBL28731889 0.83
SCHEMBL23817752 0.81 ENPEP (0.59)
SCHEMBL8015159 0.81 ENPEP (0.56)
SCHEMBL28820914 0.81 ENPEP (0.59)
Succinic Acid SCHEMBL14844489 0.81 GABRP (0.46)
SCHEMBL23051812 0.79 ALDH1A1 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 431 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630425-A1 A PROCESS FOR PREPARING PURE (3S)-PYRROLIDIN-3-OL AND PURE (3S)-PYRROLIDIN-3-OL HYDROCHLORIDE Bayer Consumer Care AG (CH) 2025-10-15 EP claimed
WO-2024121219-A1 A PROCESS FOR PREPARING PURE (3S)-PYRROLIDIN-3-OL AND PURE (3S)-PYRROLIDIN-3-OL HYDROCHLORIDE BAYER CONSUMER CARE AG (CH) 2024-06-13 WO claimed
EP-4382529-A1 A PROCESS FOR PREPARING PURE (3S)-PYRROLIDIN-3-OL AND PURE (3S)-PYRROLIDIN-3-OL HYDROCHLORIDE Bayer Consumer Care AG (CH) 2024-06-12 EP claimed
CN-113651946-B Epoxy resin curing agent and preparation method and application thereof 万华化学集团股份有限公司(CN) 2023-01-13 CN claimed
CN-113651946-A Epoxy resin curing agent and preparation method and application thereof 万华化学集团股份有限公司 2021-11-16 CN claimed
CN-110225899-A Method and composition for maintaining soil nutrients in planting field 水科学公司 2019-09-10 CN claimed
CN-107602882-A A kind of halogen-free flame-retardant master batch and preparation method thereof 成都硕屋科技有限公司 2018-01-19 CN claimed
US-9862978-B2 Method for preparing (2RS)-amino-(3S)-hydroxy-butyric acid and its derivatives AMINOLOGICS CO. LTD. (KR) 2018-01-09 US claimed
US-20160017389-A1 METHOD FOR PREPARING (2RS)-AMINO-(3S)-HYDROXY-BUTYRIC ACID AND ITS DERIVATIVES AMINOLOGICS CO., LTD. (KR) 2016-01-21 US claimed
US-8445484-B2 Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases ISTITUTO SUPERIORE DI SANITA' (IT) 2013-05-21 US claimed
EP-2189462-B9 Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases UNIV FIRENZE (IT) 2012-06-13 EP claimed
EP-2189462-B1 Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases UNIV FIRENZE (IT) 2012-01-11 EP claimed
JP-4642476-B2 2011-03-02 JP claimed
JP-2006513243-A 2006-04-20 JP claimed
EP-1581475-A1 SYNTHESIS OF (R) AND (S)-AMINOCARNITINE AND DERIVATIVES THEREOF FROM D-AND L-ASPARTIC ACID Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 2005-10-05 EP claimed
WO-2004063143-A1 SYNTHESIS FO (R) AND (S)-AMINOCARNITINE AND DERIVATIVES THEREOF FROM D-AND L-ASPARTIC ACID SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2004-07-29 WO claimed
JP-52133933-A None JP disclosed
US-20260137654-A1 COMPOUNDS AND METHODS FOR TREATING AN EPILEPTIC DISORDER THE REGENTS OF THE UNIV OF CALIFORNIA (US) 2026-05-21 US disclosed
US-4452807-A CENTRAL NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. (US) 1984-06-05 US disclosed
JP-S52133933-A 4-AMINO-3-HYDROXYBUTANOIC ACID ANILIDE, ITS ACIDIC SALTS AND PREPARATION THEREOF ONO PHARMACEUT CO LTD 1977-11-09 JP disclosed